Specifically, in regard to tumor angiogenesis, progressively more evidence suggests that angiotensin II/angiotensin II type I receptor (AT1R) signaling enhances VEGF-mediated angiogenesis, which, in turn, promotes tumor hypoxia and compensatory dissemination [8]. The gene discussed is AGTR1; the disease is neoplasm.